Click here for the CME evaluation / post-test
Activity Index
Click on the titles below to view the presentations.
Chair welcome and introduction
John P. Leonard, MD
Anti-CD20 biology, mechanisms of action and resistance
Martin Glennie, PhD
Strengths and weaknesses of current anti-CD20 therapies
David Maloney, MD, PhD
Novel anti-CD20 therapies: The next generation
Rebecca Elstrom, MD
Click here for the CME evaluation / post-test
|